Athersys, Inc. (ATHXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Athersys Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -36.40M |
| June 30, 2023 | -37.42M |
| March 31, 2023 | -31.01M |
| December 31, 2022 | -23.85M |
| September 30, 2022 | -16.61M |
| June 30, 2022 | -11.74M |
| March 31, 2022 | 0.307M |
| December 31, 2021 | 16.37M |
| September 30, 2021 | 29.35M |
| June 30, 2021 | 31.05M |
| March 31, 2021 | 38.68M |
| December 31, 2020 | 31.36M |
| September 30, 2020 | 44.16M |
| June 30, 2020 | 64.18M |
| March 31, 2020 | 26.05M |
| December 31, 2019 | 23.27M |
| September 30, 2019 | 27.00M |
| June 30, 2019 | 33.25M |
| March 31, 2019 | 36.79M |
| December 31, 2018 | 43.12M |
| September 30, 2018 | 50.34M |
| June 30, 2018 | 56.25M |
| March 31, 2018 | 47.53M |
| December 31, 2017 | 23.38M |
| September 30, 2017 | 26.07M |
| Date | Value |
|---|---|
| June 30, 2017 | 26.02M |
| March 31, 2017 | 29.22M |
| December 31, 2016 | 11.18M |
| September 30, 2016 | 16.02M |
| June 30, 2016 | 19.77M |
| March 31, 2016 | 25.43M |
| December 31, 2015 | 19.72M |
| September 30, 2015 | 15.50M |
| June 30, 2015 | 21.38M |
| March 31, 2015 | 19.02M |
| December 31, 2014 | 20.90M |
| September 30, 2014 | 26.82M |
| June 30, 2014 | 30.88M |
| March 31, 2014 | 29.66M |
| December 31, 2013 | 19.82M |
| September 30, 2013 | 11.49M |
| June 30, 2013 | 11.76M |
| March 31, 2013 | 13.00M |
| December 31, 2012 | 20.25M |
| September 30, 2012 | 1.95M |
| June 30, 2012 | 4.503M |
| March 31, 2012 | 8.018M |
| December 31, 2011 | 7.298M |
| September 30, 2011 | 10.58M |
| June 30, 2011 | 12.84M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |